Search Results - "Thomas Bigger, J."

Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association by Lichtman, Judith H, Bigger, Jr, J Thomas, Blumenthal, James A, Frasure-Smith, Nancy, Kaufmann, Peter G, Lespérance, François, Mark, Daniel B, Sheps, David S, Taylor, C Barr, Froelicher, Erika Sivarajan

“…Depression is commonly present in patients with coronary heart disease (CHD) and is independently associated with increased cardiovascular morbidity and…”
Get full text

Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes by Gerstein, Hertzel C, Miller, Michael E, Genuth, Saul, Ismail-Beigi, Faramarz, Buse, John B, Goff, Jr, David C, Probstfield, Jeffrey L, Cushman, William C, Ginsberg, Henry N, Bigger, J Thomas, Grimm, Jr, Richard H, Byington, Robert P, Rosenberg, Yves D, Friedewald, William T

“…In the ACCORD trial, a mean of 3.7 years of intensive glucose lowering increased mortality and reduced nonfatal myocardial infarctions after 5 years of…”
Get full text

Heart Rate Variability: Measurement and Clinical Utility by Kleiger, Robert E., Stein, Phyllis K., Bigger Jr, J. Thomas

“…Electrocardiographic RR intervals fluctuate cyclically, modulated by ventilation, baroreflexes, and other genetic and environmental factors that are mediated…”
Get full text

Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death by Glassman, Alexander H., Bigger, J. Thomas

“…OBJECTIVE: The authors review the mechanisms and establish the risk of torsade de pointes and sudden death with antipsychotic drugs. METHOD: They present a…”
Get full text

Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: A solution to the multicenter automatic defibrillator implantation trial (MADIT) II conundrum by BLOOMFIELD, Daniel M, STEINMAN, Richard C, RUSSO, Andrea, CHUEN TANG, BIGGER, J. Thomas, NAMEROW, Pearila B, PARIDES, Michael, DAVIDENKO, Jorge, KAUFMAN, Elizabeth S, SHINN, Timothy, CURTIS, Anne, FONTAINE, John, HOLMES, Douglas

“…In 2003, the Centers for Medicaid and Medicare Services recommended QRS duration as a means to identify MADIT II-like patients suitable for implanted cardiac…”
Get full text

Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina by Glassman, Alexander H, O'Connor, Christopher M, Califf, Robert M, Swedberg, Karl, Schwartz, Peter, Bigger, Jr, J. Thomas, Krishnan, K. Ranga Rama, van Zyl, Louis T, Swenson, J. Robert, Finkel, Mitchell S, Landau, Charles, Shapiro, Peter A, Pepine, Carl J, Mardekian, Jack, Harrison, Wilma M, for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group

“…CONTEXT Major depressive disorder (MDD) occurs in 15% to 23% of patients with acute coronary syndromes and constitutes an independent risk factor for morbidity…”
Get full text

Implantable cardioverter‐defibrillators in heart failure patients with reduced ejection fraction and diabetes by Sharma, Abhinav, Al‐Khatib, Sana M., Ezekowitz, Justin A., Cooper, Lauren B., Fordyce, Christopher B., Michael Felker, G., Bardy, Gust H., Poole, Jeanne E., Thomas Bigger, J., Buxton, Alfred E., Moss, Arthur J., Friedman, Daniel J., Lee, Kerry L., Steinman, Richard, Dorian, Paul, Cappato, Riccardo, Kadish, Alan H., Kudenchuk, Peter J., Mark, Daniel B., Peterson, Eric D., Inoue, Lurdes Y.T., Sanders, Gillian D.

“…Aim There is limited information on the outcomes after primary prevention implantable cardioverter‐defibrillator (ICD) implantation in patients with heart…”
Get full text

New York Heart Association Class and the Survival Benefit from Primary Prevention Implantable Cardioverter Defibrillators: A Pooled Analysis of 4 Randomized Controlled Trials by Friedman, Daniel J., MD, Al-Khatib, Sana M., MD, MHS, Zeitler, Emily P., MD, MHS, Han, JooYoon, BS, Bardy, Gust H., MD, Poole, Jeanne E., MD, Bigger, J. Thomas, MD, Buxton, Alfred E., MD, Moss, Arthur J., MD, Lee, Kerry L., PhD, Steinman, Richard, AB, Dorian, Paul, MD, Cappato, Riccardo, MD, Kadish, Alan H., MD, Kudenchuk, Peter J., MD, Mark, Daniel B., MD, MPH, Inoue, Lurdes Y.T., PhD, Sanders, Gillian D., PhD

“…Background Primary prevention implantable cardioverter defibrillators (ICDs) reduce all-cause mortality by reducing sudden cardiac death. There are conflicting…”
Get full text

Prophylactic Use of Implanted Cardiac Defibrillators in Patients at High Risk for Ventricular Arrhythmias after Coronary-Artery Bypass Graft Surgery by Bigger, J. Thomas

“…Many cases of sudden death are caused by sustained ventricular tachyarrhythmias. Implantable cardioverter–defibrillators accurately detect and effectively…”
Get full text

“Indeterminate” Microvolt T-Wave Alternans Tests Predict High Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction by Kaufman, Elizabeth S., Bloomfield, Daniel M., Steinman, Richard C., Namerow, Pearila B., Costantini, Ottorino, Cohen, Richard J., Bigger, J. Thomas

“…“Indeterminate” Microvolt T-Wave Alternans Tests Predict High Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction…”
Get full text

Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials by Steinberg, Benjamin A, Al-Khatib, Sana M, Edwards, Rex, Han, JooYoon, Bardy, Gust H, Bigger, J Thomas, Buxton, Alfred E, Moss, Arthur J, Lee, Kerry L, Steinman, Richard, Dorian, Paul, Hallstrom, Alfred, Cappato, Riccardo, Kadish, Alan H, Kudenchuk, Peter J, Mark, Daniel B, Inoue, Lurdes Y T, Sanders, Gillian D

“…The aim of this study was to determine if the benefit of implantable cardioverter-defibrillators (ICDs) is modulated by medical comorbidity. Primary prevention…”
Get full text

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction by Rovere, Maria Teresa La, Bigger, J Thomas, Marcus, Frank I, Mortara, Andrea, Schwartz, Peter J

“…Experimental evidence suggests that autonomic markers such as heart-rate variability and baroreflex sensitivity (BRS) may contribute to post-infarction risk…”
Get full text

Physical Health Monitoring of Patients With Schizophrenia by Marder, Stephen R., Essock, Susan M., Miller, Alexander L., Buchanan, Robert W., Casey, Daniel E., Davis, John M., Kane, John M., Lieberman, Jeffrey A., Schooler, Nina R., Covell, Nancy, Stroup, Scott, Weissman, Ellen M., Wirshing, Donna A., Hall, Catherine S., Pogach, Leonard, Pi-Sunyer, Xavier, Bigger, J. Thomas, Friedman, Alan, Kleinberg, David, Yevich, Steven J., Davis, Bonnie, Shon, Steven

“…OBJECTIVE: Schizophrenia is associated with several chronic physical illnesses and a shorter life expectancy, compared with life expectancy in the general…”
Get full text

Heart rate variability: Origins, methods, and interpretive caveats by BERNTSON, GARY G., THOMAS BIGGER JR, J., ECKBERG, DWAIN L., GROSSMAN, PAUL, KAUFMANN, PETER G., MALIK, MAREK, NAGARAJA, HAIKADY N., PORGES, STEPHEN W., SAUL, J. PHILIP, STONE, PETER H., VAN DER MOLEN, MAUROTS W.

“…Components of heart rate variability have attracted considerable attention in psychology and medicine and have become important dependent measures in…”
Get full text

Cost-Effectiveness of a Microvolt T-Wave Alternans Screening Strategy for Implantable Cardioverter-Defibrillator Placement in the MADIT-II–Eligible Population by Chan, Paul S., Stein, Kenneth, Chow, Theodore, Fendrick, Mark, Bigger, J. Thomas, Vijan, Sandeep

“…Cost-Effectiveness of a Microvolt T-Wave Alternans Screening Strategy for Implantable Cardioverter-Defibrillator Placement in the MADIT-II–Eligible Population…”
Get full text

Ambulatory Electrocardiogram-Based Tracking of T Wave Alternans in Postmyocardial Infarction Patients to Assess Risk of Cardiac Arrest or Arrhythmic Death by Verrier, Richard L., Nearing, Bruce D., Rovere, Maria Teresa La, Pinna, Gian Domenico, Mittleman, Murray A., Bigger Jr, J. Thomas, Schwartz, Peter J.

“…Introduction: This is the first study to assess T wave alternans (TWA) analyzed from routine ambulatory electrocardiograms (AECGs) to identify postmyocardial…”
Get full text

Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in CKD: A Meta-analysis of Patient-Level Data From 3 Randomized Trials by Pun, Patrick H., MD, MHS, Al-Khatib, Sana M., MD, MHS, Han, Joo Yoon, BS, Edwards, Rex, BA, Bardy, Gust H., MD, Bigger, J. Thomas, MD, Buxton, Alfred E., MD, Moss, Arthur J., MD, Lee, Kerry L., PhD, Steinman, Richard, AB, Dorian, Paul, MD, Hallstrom, Al, PhD, Cappato, Riccardo, MD, Kadish, Alan H., MD, Kudenchuk, Peter J., MD, Mark, Daniel B., MD, MPH, Hess, Paul L., MD, Inoue, Lurdes Y.T., PhD, Sanders, Gillian D., PhD

“…Background The benefit of a primary prevention implantable cardioverter-defibrillator (ICD) among patients with chronic kidney disease is uncertain. Study…”
Get full text

Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: Meta-analysis of primary prevention trials by Katritsis, Demosthenes G., MD,PhD, Siontis, Konstantinos C., MD, Bigger, J. Thomas, MD, Kadish, Alan H., MD, Steinman, Richard, BA, Zareba, Wojciech, MD,PhD, Siontis, George C.M., MD, Bardy, Gust H., MD, Ioannidis, John P.A., MD,DSc

“…Background Implantable cardioverter-defibrillators (ICDs) are recommended for the primary prevention of sudden cardiac death in patients with left ventricular…”
Get full text

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus by Cushman, William C, Evans, Gregory W, Byington, Robert P, Goff, Jr, David C, Grimm, Jr, Richard H, Cutler, Jeffrey A, Simons-Morton, Denise G, Basile, Jan N, Corson, Marshall A, Probstfield, Jeffrey L, Katz, Lois, Peterson, Kevin A, Friedewald, William T, Buse, John B, Bigger, J Thomas, Gerstein, Hertzel C, Ismail-Beigi, Faramarz

“…In a randomized trial, 4733 patients with type 2 diabetes mellitus who were at high risk for cardiovascular events received treatment aimed at a target…”
Get full text

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus by Ginsberg, Henry N, Elam, Marshall B, Lovato, Laura C, Crouse, 3rd, John R, Leiter, Lawrence A, Linz, Peter, Friedewald, William T, Buse, John B, Gerstein, Hertzel C, Probstfield, Jeffrey, Grimm, Richard H, Ismail-Beigi, Faramarz, Bigger, J Thomas, Goff, Jr, David C, Cushman, William C, Simons-Morton, Denise G, Byington, Robert P

“…In a randomized trial, 5518 patients with type 2 diabetes mellitus who were at high risk for cardiovascular events were all treated with simvastatin and…”
Get full text